Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Inflammation
Published in: Inflammation 5/2014

01-10-2014

Modulatory Effect of Whey Proteins in Some Cytokines Involved in Wound Healing in Male Diabetic Albino Rats

Author: Bahaa Kenawy Abuel-Hussien Abdel-Salam

Published in: Inflammation | Issue 5/2014

Login to get access

Abstract

The anti-inflammatory cytokines (interleukin (IL)-4 and IL-10) and the pro-inflammatory cytokines (IL-1β, IL-6, and tumor necroses factor-alpha (TNF-α)) have important functions in wound healing. Thus, the aim of this study was to determine whether dietary supplementation with whey protein could enhance normal inflammatory responses during wound healing in diabetic rats. In this study, male albino rats were divided into a wounded control group, a wounded diabetic group, and a wounded diabetic group supplemented with whey protein orally at a dose of 100 mg/kg body weight. Tested rats showed increasing wound closure in rats treated with whey protein. In addition, after 4 days of wound, modulation in IL-4, IL-10, IL-1β, IL-6, and TNF-α levels were detected. Statistical analysis of data showed significant difference between the whey-protein-treated group and either control or diabetic groups (P < 0.05). Dietary supplementation with whey protein enhances the normal inflammatory responses during wound healing in diabetic rats by modulating the levels of some anti-inflammatory and inflammatory cytokines.
Literature
1.
Werner, S., and R. Grose. 2003. Regulation of wound healing by growth factors and cytokines. Physiological Reviews 83: 835–870.PubMed
2.
Mercado, A.M., N. Quan, D.A. Padgett, J.F. Sheridan, and P.T. Marucha. 2002. Restraint stress alters the expression of interleukin-1 and keratinocyte growth factor at the wound site: an in situ hybridization study. Journal of Neuroimmunology 129: 74–83.PubMedCrossRef
3.
Singer, A.J., and R.A. Clark. 1999. Cutaneous wound healing. New England Journal of Medicine 341: 738–746.PubMedCrossRef
4.
Delgado, A.V., A.T. McManus, and J.P. Chambers. 2003. Production of tumor necrosis factor-alpha, interleukin 1-beta, interleukin 2, and interleukin 6 by rat leukocyte subpopulations after exposure to substance P. Neuropeptides 37: 355–361.PubMedCrossRef
5.
Molloy, T., Y. Wang, and G. Murrell. 2003. The roles of growth factors in tendon and ligament healing. Sports Medicine 33: 381–394.PubMedCrossRef
6.
Vegesna, V., W.H. McBride, J.M. Taylor, and H.R. Withers. 1995. The effect of interleukin-1 beta or transforming growth factor-beta on radiation-impaired murine skin woundhealing. Journal of Surgical Research 59: 699–704.PubMedCrossRef
7.
Anjana, G., K. Sandeep, K. Dilip, and K.B. Ashok. 2010. Wound healing potential of Ocimum sanctum Linn. With induction of tumor necrosis factor-α. Indian Journal of Experimental Biology 48: 402–406.
8.
Molly, M.M., M.F. Holly, M.Z. Paluch, Vummidi Giridhar Premkumar, Carol A. Mercer, Sara C. Kozma, and F.D. Angela. 2010. Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. Journal of Immunol 184: 7219–7228.CrossRef
9.
Kondo, T., and T. Ohshima. 1996. The dynamics of inflammatory cytokines in the healing process of mouse skin wound: a preliminary study for possible wound age determination. International Journal of Legal Medicine 108: 231–236.PubMedCrossRef
10.
Paquet, P., and G.E. Pierard. 1996. Interleukin-6 and the skin. International Archives of Allergy and Immunology 109: 308–317.PubMedCrossRef
11.
Sawamura, D., X. Meng, S. Ina, M. Sato, K. Tamai, K. Hanada, and I. Hashimoto. 1998. Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes. Journal of Immunology 161: 5633–5639.
12.
Turksen, K., T. Kupper, L. Degenstein, I. Williams, and E. Fuchs. 1992. Interleukin 6: insights to its function in skin by overexpression in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 89: 5068–5072.PubMedCrossRefPubMedCentral
13.
Peyron, E., and J. Banchereau. 1994. Interleukin-4: Structure, function, and clinical aspects. European Journal of Dermatology 4: 181–188.
14.
Gillery, P., C. Fertin, J.F. Nicolas, F. Chastang, B. Kalis, J. Banchereau, and F.X. Maquart. 1992. Interleukin-4 stimulates collagen gene expression in human fibroblast monolayer cultures. Potential role in fibrosis. FEBS Letters 302: 231–234.PubMedCrossRef
15.
Ve´ronique, S., R. Laurent, G. Gaston, B. Philippe, G. Moncef, B. Philippe, and M. Francois-Xavier. 2000. Implication of interleukin-4 in wound healing. Laboratory Investigation 80: 1337–1343.CrossRef
16.
Moore, K.W., R. de Waal Malefytq, R.L. Coffman, and A. O’Garra. 2001. Interleukin-10 and the interleukin-10 receptor. Annual Review of Immunology 19: 683–765.PubMedCrossRef
17.
Sato, Y., T. Ohshima, and T. Kondo. 1999. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochemical and Biophysical Research Communications 265: 194–199.PubMedCrossRef
18.
Moore, K.W., A. O’Garra, R. de Waal Malefyt, P. Vieira, and T.R. Mosmann. 1993. Interleukin-10. Annual Review of Immunology 11: 165–190.PubMedCrossRef
19.
Engelhardt, E., A. Toksoy, M. Goebeler, S. Debus, E.B. Brocker, and R. Gillitzer. 1998. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. American Journal of Pathology 153: 1849–1860.PubMedCrossRefPubMedCentral
20.
Pari, L., and P. Murugan. 2007. Tetrahydrocurcumin prevents brain lipid peroxidation in streptozotocin-induced diabetic rats. Journal of Medicinal Food 10: 323–329.PubMedCrossRef
21.
Zi-Qing, L., K. Toshikazu, I. Yuko, T. Tatsunori, and M. Naofumi. 2003. Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. Journal of Leukocyte Biology 73: 713–721.CrossRef
22.
Zhang, X., M. Kohli, Q. Zhou, D.T. Graves, and S. Amar. 2004. Short and long-term effects of IL-1 and TNF antagonists on periodontal wound healing. Journal of Immunology 173: 3514–3523.CrossRef
23.
Dinarello, C.A. 1993. Modalities for reducing interleukin-1 activity in disease. Immunology Today 14: 155–159.CrossRef
24.
Narayanan, S., A. Glasser, Y.S. Hu, and A.M. McDermott. 2005. The effectof interleukin-1 on cytokine gene expression by human corneal epithelial cells. Experimental Eye Research 80: 175–183.PubMedCrossRef
25.
Takami, Y., T. Motoki, I. Yamamoto, and E. Gohda. 2005. Synergistic induction of hepatocyte growth factor in human skin fibroblasts by the inflammatory cytokines interleukin-1 and interferon-gamma. Biochemical and Biophysical Research Communications 327: 212–217.PubMedCrossRef
26.
Dasu, M.R., R.E. Barrow, M. Spies, and D.N. Herndon. 2003. Matrix metalloproteinase expression in cytokine stimulated human dermal fibroblasts. Burns 29: 527–531.PubMedCrossRef
27.
Kopf, M., H. Baumann, G. Freer, M. Freudenberg, M. Lamers, T. Kishimoto, R. Zinkernagel, H. Bluethmann, and G. Kohler. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368: 339–342.PubMedCrossRef
28.
Sato, Y., and T. Ohshima. 2000. The expression of mRNA of proinflammatory cytokines during skin wound healing in mice: a preliminary study for forensic wound age estimation (II). International Journal of Legal Medicine 113: 140–145.PubMedCrossRef
29.
Gallucci, R.M., P.P. Simeonova, J.M. Matheson, C. Kommineni, J.L. Guriel, T. Sugawara, and M.I. Luster. 2000. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB Journal 14: 2525–2531.PubMedCrossRef
30.
Natsume, M., H. Tsuji, A. Harada, M. Akiyama, T. Yano, H. Ishikura, I. Nakanishi, K. Matsushima, S. Kaneko, and N. Mukaida. 1999. Attenuated liver fibrosis and depressed serum albumin levels in carbon tetrachloridetreated IL-6-deficient mice. Journal of Leukocyte Biology 66: 601–608.PubMed
31.
Greenwel, P., J. Rubin, M. Schwartz, E.L. Hertzberg, and M. Rojkind. 1993. Liver fat-storing cell clones obtained from a CCl4-cirrhotic rat are heterogeneous with regard to proliferation, expression of extracellular matrix components, interleukin-6, and connexin 43. Laboratory Investigation 69: 210–216.PubMed
32.
Yunsook, L., A.L. Mark, M. Tammy, and Bray. 2006. Dietary supplementation of N-acetylcysteine enhances early inflammatory responses during cutaneous wound healing in protein malnourished mice. Journal of Nutritional Biochemistry 17: 328–336.CrossRef
33.
Frank, S., G. Hubner, G. Breier, M.T. Longaker, D.G. Greenhalgh, and S. Werner. 1995. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. Journal of Biological Chemistry 270: 12607–12613.PubMedCrossRef
34.
Bickel, M., S.M. Nothen, K. Freiburghaus, and D. Shire. 1996. Chemokine expression in human oral keratinocyte cell lines and keratinized mucosa. Journal of Dental Research 75: 1827–1834.PubMedCrossRef
35.
Nian, M., P. Lee, N. Khaper, and P. Liu. 2004. Inflammatory cytokines and postmyocardial infarction remodeling. Circulation Research 94: 1543–1553.PubMedCrossRef
36.
Serpier, H., P. Gillery, V. Salmon-Her, R. Garnotel, N. Georges, B. Kalis, and F.X. Maquart. 1997. Antagonistic effects of interferon-g and interleukin-4 on fibroblast cultures. Journal of Investigative Dermatology 109: 158–162.PubMedCrossRef
37.
Kucukcelebi, A., R.H.C. Harries, P.J. Hennessey, L.G. Phillips, L.D. Broemeling, D. Listengarten, F. Ko, S. Narula, and M.C. Robson. 1995. In vivo characterization of interleukin-4 as a potential wound healing agent. Wound Repair and Regeneration 3: 49–58.PubMedCrossRef
38.
Leonardi, A., R. Cortivo, I. Fregona, M. Plebani, A.G. Secchi, and G. Abatangelo. 2003. Effects of Th2 cytokines on expression of collagen, MMP-1, and TIMP-1 in conjunctival fibroblasts. Investigative Ophthalmology and Vision Science 44: 183–189.CrossRef
39.
Sabine, A., S.W. Eming, B. Philippe, W. Claudia, S. Lisa, U. Olaf, M. Jeffrey, T.K. Davidson, and R. Axel. 2007. Accelerated Wound Closure in Mice Deficient for Interleukin-10. American Journal of Pathology 170: 188–202.CrossRef
40.
Liechty, K.W., N.S. Adzick, and T.M. Crombleholme. 2000. Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. Cytokine 12: 671–676.PubMedCrossRef
41.
Gamal, B. 2012. Supplementation with undenatured whey protein during diabetes mellitus improves the healing and closure of diabetic wounds through the rescue of functional long-lived wound macrophages. Cellular Physiology and Biochemistry 29: 571–582.CrossRef
42.
Gamal, B., M.B. Badr, H.M. Mohamed, M. Mohamed, M.R. Danny, and G. Olivier. 2012. Treatment of diabetic mice with undenatured whey protein accelerates the wound healing process by enhancing the expression of MIP-1α, MIP-2, KC, CX3CL1 and TGF-β in wounded tissue. BMC Immunology 13: 32.CrossRef
Metadata
Title
Modulatory Effect of Whey Proteins in Some Cytokines Involved in Wound Healing in Male Diabetic Albino Rats
Author
Bahaa Kenawy Abuel-Hussien Abdel-Salam
Publication date
01-10-2014
Publisher
Springer US
Published in
Inflammation / Issue 5/2014
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-014-9888-z

Other articles of this Issue 5/2014

Inflammation 5/2014 Go to the issue

OriginalPaper

Oxidative Stress and Inflammation Are Differentially Affected by Atorvastatin, Pravastatin, Rosuvastatin, and Simvastatin on Lungs from Mice Exposed to Cigarette Smoke

OriginalPaper

CRP Gene (1059G>C) Polymorphism and Its Plasma Levels in Ischemic Stroke and Hemorrhagic Stroke in a South Indian Population

OriginalPaper

Protective Effect of Curcumin on Acute Airway Inflammation of Allergic Asthma in Mice Through Notch1–GATA3 Signaling Pathway

OriginalPaper

Increased Serum GP88 (Progranulin) Concentrations in Rheumatoid Arthritis

OriginalPaper

Anti-septic Effects of Fisetin In Vitro and In Vivo

OriginalPaper

Glyceraldehyde-3-phosphate Dehydrogenase is an Inappropriate Housekeeping Gene for Normalising Gene Expression in Sepsis
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits